Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Michael G. Scott"'
Autor:
Nadia Farhanah Syafhan, Sayer Al Azzam, Steven D. Williams, Wendy Wilson, Jayne Brady, Peter Lawrence, Mark McCrudden, Mustafa Ahmed, Michael G. Scott, Glenda Fleming, Anita Hogg, Claire Scullin, Robert Horne, Harblas Ahir, James C. McElnay
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1 (2021)
Background Changing demographics across the UK has led to general practitioners (GPs) managing increasing numbers of older patients with multi-morbidity and resultant polypharmacy. Through government led initiatives within the National Health Service
Externí odkaz:
https://doaj.org/article/cf14f8a57d264625853dd7e1fd576721
Autor:
Peter Wilson, John Barron, Kathryn Burnett, Glenda Fleming, Michael G. Scott, Linda O'Hare, Catherine Goudy, Suzanne Martin
Publikováno v:
Journal of Patient Safety and Risk Management. 27:42-49
This article outlines the purchasing process for personal protective equipment that was established for Health and Social Care in Northern Ireland in response to the outbreak of coronavirus disease 2019. The Business Services Organisation Procurement
Autor:
Jason Murray, Tendai Muruko, Chris I R Gill, M Patricia Kearney, David Farren, Michael G Scott, Geoff McMullan, Nigel G Ternan
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182624 (2017)
Healthcare acquired infections (HAI) pose a great threat in hospital settings and environmental contamination can be attributed to the spread of these. De-contamination and, significantly, prevention of re-contamination of the environment could help
Externí odkaz:
https://doaj.org/article/a5879a1ba9fd41a4a8bb0e001c16303f
Autor:
Wendy Wilson, Michael G. Scott, Anita Hogg, James C. McElnay, Mustafa Ahmed, Glenda Fleming, Harblas Ahir, Rob Horne, Claire Scullin, Steven D. Williams, Nadia Farhanah Syafhan, Peter Lawrence, Mark Stephen McCrudden, Sayer Al Azzam, Jayne Brady
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1, Pp 1-15 (2021)
Journal of Pharmaceutical Policy and Practice
Syafhan, N F, Al Azzam, S, Williams, S D, Wilson, W, Brady, J, Lawrence, P, McCrudden, M, Ahmed, M, Scott, M G, Fleming, G, Hogg, A, Scullin, C, Horne, R, Ahir, H & McElnay, J C 2021, ' General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial ', Journal of Pharmaceutical Policy and Practice, vol. 14, no. 1, 4 . https://doi.org/10.1186/s40545-020-00279-3
Journal of Pharmaceutical Policy and Practice
Syafhan, N F, Al Azzam, S, Williams, S D, Wilson, W, Brady, J, Lawrence, P, McCrudden, M, Ahmed, M, Scott, M G, Fleming, G, Hogg, A, Scullin, C, Horne, R, Ahir, H & McElnay, J C 2021, ' General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial ', Journal of Pharmaceutical Policy and Practice, vol. 14, no. 1, 4 . https://doi.org/10.1186/s40545-020-00279-3
BackgroundChanging demographics across the UK has led to general practitioners (GPs) managing increasing numbers of older patients with multi-morbidity and resultant polypharmacy. Through government led initiatives within the National Health Service,
Autor:
Ann Sinéad Doherty, Gary Adamson, John Mallett, Carmel Darcy, Anne Friel, Michael G. Scott, EF Ruth Miller
Publikováno v:
Research in socialadministrative pharmacy : RSAP. 18(9)
Whilst attention has been paid within the literature to examining potentially inappropriate prescribing (PIP) for older adults in a variety of care settings, less is known about the extent within intermediate care. Furthermore, few studies have exami
Autor:
Rose Sharkey, Maureen Spargo, Michael G. Scott, Brendan Moore, Anne Friel, Glenda Fleming, Cairine Gormley
Publikováno v:
Pharmacy: Journal of Pharmacy Education and Practice
Pharmacy, Vol 9, Iss 177, p 177 (2021)
Pharmacy, Vol 9, Iss 177, p 177 (2021)
Medicines optimisation for those with respiratory conditions can have a significant impact on clinical outcomes and substantial efficiency gains for health care. Consultant pharmacists are experts working at the top of their specialism in four main p
Autor:
Eimear O'Dwyer, Claire Kavanagh, Niamh McMahon, Michael G. Scott, Róisín Purcell, Morgan Crowe
Publikováno v:
Age and Ageing. 48:iii1-iii16
Background This study assessed the pharmacist role in an 80 bed residential care unit by: Quantifying the number and type of pharmacist interventions made and their acceptance rate.Assessing impact of pharmacist interventions on patient care.Assessin
Autor:
David Farren, Fiona Glimore, Munther S. Alnajjar, Glenda Fleming, Mamoon A. Aldeyab, Michael G. Scott, James McElnay, M. P. Kearney
Publikováno v:
Alnajjar, M S, Aldeyab, M A, Scott, M G, Kearney, M P, Fleming, G, Glimore, F, Farren, D & McElnay, J C 2019, ' Influence of primary care antibiotic prescribing on incidence rates of multidrug-resistant Gram-negative bacteria in hospitalised patients ', Infection . https://doi.org/10.1007/s15010-019-01305-6
Purpose: Use of antibiotics can give rise to the selection of resistant bacteria. It remains unclear whether antibiotic use in primary care can influence bacterial resistance incidence in patients when hospitalised. The aim of this study is to explor
Autor:
Sah Russel, Jorie Versmissen, Wim J R Rietdijk, TZ Zuppini, AL Lubich, RB van den Berg, JL G Le Grand, FP Pieraccini, SP Pagliarino, J Liang, Jmga Schols, MK Kemogni, FN Nagele, SB Berlinghini, RC Cabuk, C van Nieuwkoop, R Mc Menamin, RG Grinta, Hjm van Kan, J Tournoy, MG Gambera, Dmk Duchek-Mann, J Hanley, Fef Hogenhuis, J Diepstraten, GC Cohet, B Maat, F Boutkourt, LA Agnoletto, Wong, Mdc Di Carlo, GS Stemer, JR Rijo, Miriam C Faes, DM Mendes, MV Veyrier, C Bufarini, J Aleman, Fv Verri, Michael G. Scott, Npk Pons-Kerjean, GR Rametta, F Sombogaard, FP Pappalardo, LR Rossi, LE Visser, FF Falcao, Kfm Keijzers, WL Hemminga, S Andreassi, RA Kranenburg, L Van der Linden, JS Soares, Mhw Kappers, N Goodfellow, MF Falcao, Hugo van der Kuy, GG Gambarelli, M Ezinga, MC Candela, L Ashfield, KH Heitzeneder, Harmke A Polinder-Bos, Melvin Lafeber, KB Blum, K Guda, CM Masini, EL Loche, Mqg Gorgas, LF Fantini, FM de Stoppelaar, NJ Fitzhugh, LM Andrews, Cgy García Yubero, Müller, Kml Crommentuijn, GC Callens, GB Boni, Jamc Verstijnen, Simon P. Mooijaart, Eric Boersma, H Bell, Ema Slob, KB Bini, DH Haider, R Moorlag, GO Oka, M Patel, CZ Zenico, Z Safipour, Glenda Fleming, Pmg Filius, IM Martignoni, PC Chessa, Hajm de Wit, DS Deben, Pgj ter Horst, Haw van Onzenoort, S Lim, Imm van Haelst, MC Canonici, EC Capone, IC Hoogendoorn-de Graaf, L Saleh, KN Nemec, TM Bosch, PM Peverini, TF Forsthuber, FM Marchesini, MM Ebbens, RT Tessari, PC Wierenga, NL Lindner, LJ Ellerbroek, A Bulsink, Ams Schimizzi, Roos S G Sablerolles, Kpgm Hurkens, BE Bosma, Pkc Janssen, Mah Huebler, FC Caruso, AM Maiworm, E Jong, Mam Vromen, RW Van Etten, M Miarons, EM Kemper, Akb Bengaard, Eam Slijfer, CN Ghazarian, PD van der Linden, Schwap, LL Krens, M van Heuckelum, CM Maesano, Ljj Derijks, MT Tardella, I Cornelissen-Wesseling, DL Hilarius, Jdj Verdonk, EV Viegas, IC Carmo, P van Wijngaarden, AG Otten-Helmers, ZB Bisoffi, G M Martini, Janneke A L van Kempen, SC van Dijk, LC Hendriksen, M Maragna, Emp Platania, E Roobol-Meuwese, B Dilek, E Boemaars, FS Salaffi, Lph Portillo Horcajada, HF Farinha, Z Getrouw, Bob P A van de Loo, A Vos, Mbh Houlind, EE Roelofsen, Solano
Publikováno v:
The Lancet Healthy Longevity, 2(3), e163-e170. Elsevier Ltd.
The Lancet. Healthy Longevity
The Lancet Healthy Longevity, 2(3), e163-e170. Elsevier Ltd
The Lancet Healthy Longevity, 2(3), e163-e170. Lancet Publishing Group
The Lancet. Healthy Longevity, Vol 2, Iss 3, Pp e163-e170 (2021)
The Lancet Healthy Longevity
The Lancet Healthy Longevity, 2(3), E163-E170. ELSEVIER
The Lancet. Healthy Longevity
The Lancet Healthy Longevity, 2(3), e163-e170. Elsevier Ltd
The Lancet Healthy Longevity, 2(3), e163-e170. Lancet Publishing Group
The Lancet. Healthy Longevity, Vol 2, Iss 3, Pp e163-e170 (2021)
The Lancet Healthy Longevity
The Lancet Healthy Longevity, 2(3), E163-E170. ELSEVIER
Background: During the COVID-19 pandemic, the scarcity of resources has necessitated triage of critical care for patients with the disease. In patients aged 65 years and older, triage decisions are regularly based on degree of frailty measured by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62769c4e206f6c565ea3d2e7353bb31f
https://pure.eur.nl/en/publications/63631910-99ae-4894-bf51-70737137322d
https://pure.eur.nl/en/publications/63631910-99ae-4894-bf51-70737137322d
Autor:
Pilar Retamar, Xavier Bertrand, David Farren, Arielle Beyaert, Didier Hocquet, Geraldine Conlon-Bingham, Mamoon A. Aldeyab, J.M. López-Lozano, Timothy Lawes, César Nebot, Jesús Rodríguez-Baño, Ian M. Gould, Michael G. Scott, Gábor Kardos, Nieves Gonzalo-Jiménez, Adina Fésűs
Publikováno v:
Nature Microbiology
Nature Microbiology, Nature Publishing Group, 2020, 5 (11), pp.1449-1449. ⟨10.1038/s41564-020-00796-6⟩
Nature Microbiology, Nature Publishing Group, 2020, 5 (11), pp.1449-1449. ⟨10.1038/s41564-020-00796-6⟩
International audience; An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c4204ca138f73420d99b1326843002
https://hal.archives-ouvertes.fr/hal-03053749
https://hal.archives-ouvertes.fr/hal-03053749